Evaluating the Effects of a Self-help Mobile Phone Application on Worry and Overthinking in Young Adults Aged Between 16 and 24.
1 other identifier
interventional
236
1 country
1
Brief Summary
This project seeks to understand if a new self-help mobile phone application (called MyMoodCoach) is effective at reducing worry and overthinking, prominent risk factors that predict reduced well-being and poor mental health. As a primary outcome, the investigators are predicting that people who use the app will report more significant reductions on measures of overthinking than those who do not. The investigators also predict that people who use the app will report more significant reductions in measures of worry as well as reported symptoms of depression and anxiety. Further, it is predicted that people who use the app will report a significantly higher increase in their well-being compared to those who do not.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 14, 2021
CompletedFirst Submitted
Initial submission to the registry
June 22, 2021
CompletedFirst Posted
Study publicly available on registry
July 6, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 13, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
January 30, 2022
CompletedFebruary 1, 2022
January 1, 2022
7 months
June 22, 2021
January 30, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Change in rumination using the Ruminative Response Scale (RRS)
A well established 22-item measure of pathological rumination which predicts subsequent depression.
Change from baseline at 6 weeks
Secondary Outcomes (4)
Change in worry using the Penn State Worry Questionnaire (PSWQ)
Change from baseline at 6 weeks
Change in symptoms for depression using the Patient Health Questionnaire-9 (PHQ-9)
Change from baseline at 6 weeks
Change in wellbeing using the Warwick-Edinburgh Mental Well Being Scale (WEMWBS)
Change from baseline at 6 weeks
Change in symptoms for anxiety using the Generalized Anxiety Disorder-7 (GAD-7)
Change from baseline at 6 weeks
Other Outcomes (5)
Change in worry using the Penn State Worry Questionnaire (PSWQ)
Change from 6 weeks post randomisation at 12 weeks post randomisation
Change in rumination using the Ruminative Response Scale (RRS)
Change from 6 weeks post randomisation at 12 weeks post randomisation
Change in symptoms for depression using the Patient Health Questionnaire-9 (PHQ-9)
Change from 6 weeks post randomisation at 12 weeks post randomisation
- +2 more other outcomes
Study Arms (2)
waiting list control group
ACTIVE COMPARATORParticipants randomly allocated to this arm will be offered self-help components within a mobile phone app to target worry and rumination after a 6-week wait.
treatment group
EXPERIMENTALParticipants randomly allocated to this arm will be offered self-help components within a mobile phone app to target worry and rumination immediately.
Interventions
The self-help app includes self-monitoring, psychoeducation and active self-help exercises. The self-monitoring includes daily mood ratings and an ecological momentary assessment option (MoodTracker) for more detailed analysis of mood, worry, activity and situational context. The digital self-help provides psychoeducation, tips, advice, exercises and training for each individual focused on reducing worry and rumination, using strategies from the proven rumination-focused CBT intervention. The app includes text, pictures, audio-recordings, animations, audio-exercises to practice (e.g., self-compassion, relaxation, concreteness exercises), and questionnaires with tailored feedback. The app is designed for iOS and Android use.
Eligibility Criteria
You may qualify if:
- aged 16 to 24 years old (inclusive)
- currently based in the UK
- possess a basic literacy in English
- able to provide informed consent
- reporting elevated levels of worry and rumination, defined here as scoring above the 50th percentile (i.e., top-half of scale) on either the RSS (\>34) or the PSWQ (\>41)
- have regular access to a smartphone (android or iOS).
You may not qualify if:
- reporting highly elevated symptoms of depression indicating more specialist treatment is required (PHQ-9 \> 20)
- self-report of active suicidality
- self-report currently receiving psychological therapy, counseling, or psychiatric medication, including antidepressants, for a current mental health condition
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Exeter
Exeter, Devon, EX2 5DY, United Kingdom
Related Publications (2)
Edge D, Newbold A, Ehring T, Rosenkranz T, Frost M, Watkins ER. Reducing worry and rumination in young adults via a mobile phone app: study protocol of the ECoWeB (Emotional Competence for Well-Being in Young Adults) randomised controlled trial focused on repetitive negative thinking. BMC Psychiatry. 2021 Oct 21;21(1):519. doi: 10.1186/s12888-021-03536-0.
PMID: 34674669BACKGROUNDEdge D, Watkins E, Newbold A, Ehring T, Frost M, Rosenkranz T. Evaluating the Effects of a Self-Help Mobile Phone App on Worry and Rumination Experienced by Young Adults: Randomized Controlled Trial. JMIR Mhealth Uhealth. 2024 Aug 13;12:e51932. doi: 10.2196/51932.
PMID: 39137411DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Ed R Watkins, Professor
Exeter University
- PRINCIPAL INVESTIGATOR
Dan J Edge, MRes
Exeter University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The analysis team members will be blind to the randomisation process and group allocation of participants
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Trainee Clinical Psychologist
Study Record Dates
First Submitted
June 22, 2021
First Posted
July 6, 2021
Study Start
May 14, 2021
Primary Completion
December 13, 2021
Study Completion
January 30, 2022
Last Updated
February 1, 2022
Record last verified: 2022-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- The study protocol and informed consent form will be uploaded with this registration. The SAP is included in the study protocol. Data Access: Post-analysis, the final anonymised dataset will preferentially be stored in Open Research Exeter (ORE), the University of Exeter's open access repository. The data will be available from 24 months after trial completion (end of December 2021).
- Access Criteria
- Access to these data is permitted but controlled through requests made via the repository to a review panel from the trial team, led by the chief investigator, which will assess requests on scientific merit and commercial sensitivity. Although use is permitted, this will be on the basis that the source of the data is acknowledged (including the funder) and it includes reference to the data set 'handle', and a data access agreement is signed, subject to approval by funder.
De-identified individual participant and clinical and economic data reported in publications will be made available through the University of Exeter's Institutional Repository - Open Research Exeter (see https://ore.exeter.ac.uk).